SCHEMBL181324

SCHEMBL181324

O=C(O)OC[C@H](OC(=O)O)[C@H](O)CO

nearest known ligand 0.34

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 1/20 0.34
PRKCA P17252 1/20 0.34
LMNA P02545 1/20 0.32
USP2 O75604 1/20 0.32
SLCO1B1 Q9Y6L6 1/20 0.32
OR51E2 Q9H255 1/20 0.31
TDP1 Q9NUW8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17727607 0.83 PDE4A (0.37) PDE4APRKCALMNAUSP2SLCO1B1
SCHEMBL295583 0.82 TDP1 (0.37) TDP1
SCHEMBL1730349 0.82 TDP1 (0.37) TDP1
SCHEMBL376766 0.78 TDP1 (0.32) TDP1
SCHEMBL16894036 0.78 ALDH1A1 (0.42) PDE4APRKCALMNAUSP2SLCO1B1
SCHEMBL7071675 0.76 TDP1 (0.47) TDP1
SCHEMBL8516629 0.76 TDP1 (0.33) TDP1
SCHEMBL7170688 0.74 PDE4A (0.52) PDE4APRKCALMNAUSP2SLCO1B1
SCHEMBL5139535 0.74 PDE4A (0.46) PDE4APRKCALMNAUSP2SLCO1B1
SCHEMBL20423633 0.74 TDP1 (0.36) TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 406 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025108113-A1 SECONDARY BATTERY AND ELECTRIC DEVICE 欣旺达动力科技股份有限公司 2025-05-30 WO claimed
CN-115850121-B Erythritol-based polyurethane prepolymer and synthesis and application thereof 中国科学院天津工业生物技术研究所 2024-07-19 CN claimed
CN-115850121-A Erythritol-based polyurethane prepolymer and synthesis and application thereof 中国科学院天津工业生物技术研究所 2023-03-28 CN claimed
EP-2170897-B1 METHODS FOR ONE-POT N-DEMETHYLATION/N-ACYLATION OF MORPHINE AND TROPANE ALKALOIDS UNIV BROCK (CA) 2013-08-21 EP claimed
US-7999104-B2 Methods for one-pot N-demethylation/N-acylation of morphine and tropane alkaloids BROCK UNIVERSITY (CA) 2011-08-16 US claimed
EP-2170897-A1 METHODS FOR ONE-POT N-DEMETHYLATION/N-ACYLATION OF MORPHINE AND TROPANE ALKALOIDS Brock University (CA) 2010-04-07 EP claimed
WO-2009003270-A1 METHODS FOR ONE-POT N-DEMETHYLATION/N-ACYLATION OF MORPHINE AND TROPANE ALKALOIDS BROCK UNIVERSITY (CA) 2009-01-08 WO claimed
US-20090005565-A1 METHODS FOR ONE-POT N-DEMETHYLATION/N-ACYLATION OF MORPHINE AND TROPANE ALKALOIDS BROCK UNIVERSITY 2009-01-01 US claimed
US-5401634-A Stable biologically active fluorochemical emulsions MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1995-03-28 US claimed
EP-0184710-A2 Magnetic microspheres BAYER AG (DE) 1986-06-18 EP claimed
US-12606830-B2 Protected antibody-drug and aptamer-drug conjugates KOSAK KENNETH MICHAEL (US) 2026-04-21 US disclosed
US-12600887-B2 One-part adhesive for thermoplastic urethanes LORD CORPORATION (US) 2026-04-14 US disclosed
US-20250352663-A1 Nanoclusters Functionalized with Adenosine Triphosphate or an Analogue and Their Use UNIV LELAND STANFORD JUNIOR (US) 2025-11-20 US disclosed
EP-4613796-A1 STAR-SHAPED POLYMERS Evonik Operations GmbH (DE) 2025-09-10 EP disclosed
US-20250177558-A1 Functionalized Nanoclusters and Their Use in Treating Bacterial Infections THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY 2025-06-05 US disclosed
US-4528267-A Fluorometirc enzyme inhibition immunoassay for measuring potency of allergen extracts AXIONICS, INC. (US) 1985-07-09 US disclosed
EP-0124103-A2 Fluorometric assay of chymopapain and reagents therefor BioWhittaker, Inc. (US) 1984-11-07 EP disclosed
EP-0119613-A2 Fluorometric assay of total IgE level and reagents therefor BioWhittaker, Inc. (US) 1984-09-26 EP disclosed
EP-0107832-A2 Stable allergenic extracts and methods MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1984-05-09 EP disclosed
EP-0106324-A2 Fluorometric assay of allergic reactions and reagents therefor MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1984-04-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12606830-B2 Protected antibody-drug and aptamer-drug conjugates PABPC1, PABPC4, ABCG2 PDE4A 1179/4885PRKCA 2175/4885LMNA 171/4885
US-20090005565-A1 METHODS FOR ONE-POT N-DEMETHYLATION/N-ACYLATION OF MORPHINE AND TROPANE ALKALOIDS HNMT, PNMT, NNMT PDE4A 1269/4885PRKCA 4333/4885LMNA 4086/4885
US-12600887-B2 One-part adhesive for thermoplastic urethanes TET3, TET1, KDM3A PDE4A 4838/4885PRKCA 2835/4885LMNA 2785/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.